Abstract Submission!

Abstract Submission Details:

Submit abstract online : Submit Here

Send your abstract by mail: diabetes@europemeet.com

Download abstract submission template : Abstract template

Terms: 

Abstracts must be submitted on the understanding that they have not been presented elsewhere (except in the form of a thesis) and are not currently under consideration by another conference. The submitting speaker should ensure that the abstract publication has been approved by all other co-authors.

Mode of Presentation

  1. Oral presentation
  2. Poster presentation

Language

All abstracts must be written exclusively in English (including the title, abstract text, author names and affiliations).
Please provide the following:
Presenting author’s contact details including full mailing address, phone number and email address.
Affiliation details of all authors: Department, institution/hospital, city, state (if relevant), country
Poster Guidelines: 
  • Present numerical data in the form of graphs, rather than tables (graphs make trends in the data much more evident).If data must be presented in table-form, Keep it Simple.
  • Visuals should be simple and bold.
  • Posters with 800 words or less are perfect. Avoid submitting compactly packed, high word-count posters.
  • Organize your poster into subdivisions, e.g., Introduction, Methods, Results, Discussion, Conclusions, and Literature Cited (avoid using too many citations).
  • Use bright colors to enhance the detail.
  • Text should be readable from five feet distance.
  • Besides your project, the text could also include future research plans or questions.
  • Each poster should be approximately 1x1 M long.
  • The title, contents and the author’s information should be clearly visible from a distance of 1-2 feet.

Contact Details: 
Monika
Conference Manager
Global Diabetes 2019
47 Churchfield Road, London, W3 6AY, UK
Phone: +44-203 936-3178 
E: diabetes@europemeet.com

Comments

Post a Comment

Popular posts from this blog

What causes a red spot on the eye?

Image
A red spot on the eye may look worrying, but it is rarely a medical emergency. Usually, a red spot on the eye occurs when blood collects under the conjunctiva due to a subconjunctival hemorrhage. A red spot on the eye, or subconjunctival hemorrhage, usually occurs as a result of increased blood pressure. In some cases, subconjunctival hemorrhages can appear without any identifiable cause. Rare causes of subconjunctival hemorrhages include: high blood pressure taking blood thinners medical disorders that cause bleeding and  diabetes Diabetic Retinopathy Diabetic Retinopathy can also lead to a red spot on the eye. This occurs when blood vessels in the eye break due to high blood sugar levels. Blood from broken or leaking vessels can cause "floaters" or dark spots in the vision. People may not realize they have diabetic retinopathy until it affects their vision. Symptoms of diabetic retinopathy include: floaters blurred vision re...
Read more

Diabetes: Can cheese control blood sugar?

Image
A new study shows that cheese improved insulin sensitivity in prediabetic rats, but industry funded the research. Can people with diabetes benefit from eating cheese? According to the American Diabetes Association (ADA ), 30.3 million adults in the United States live with diabetes, and the condition is the seventh leading cause of death in the U.S. In type 2 diabetes, a person's body is unable to properly use insulin to absorb sugar from the blood into cells. Cheese loaded with fat and salt is a contentious subject when it comes to diabetes and health in general.  While many people enjoy it as part of their diet, the ADA recommend reduced-fat varieties over regular fat cheese. The big problem with research into the effects of cheese is that many studies receive backing by dairy organizations. A recent study adds fuel to the fire by showing that both regular-fat and low-fat cheese improve insulin sensitivity in prediabetic rats. Dairy Farmers of Cana...
Read more

Major US grant to be spent on stem cell research within type 1 diabetes

Image
A major grant has been awarded to a US researcher who will further investigate stem cell therapies for type 1 diabetes treatments. Xiaojun "Lance" Lian, assistant professor of biomedical engineering at Penn State University, is one of three recipients of the College of Engineering's ENGineering for Innovation &Entrepreneurship (ENGINE) grant. Now in its fifth year, ENGINE grants provide financial support to early-stage research results through a proof-of-concept phase. Professor Lian and his team have already exploring making functional beta cells from stem cells. But there are hurdles, and transplanting beta cells does not always work. One of the key issues is the lack of robust cell culture systems that enable stem cells to be differentiated into beta cells. Prof Lian has developed a method which he believes may address this problem. He said: "Our new method is an improvement on previous growth-factor dependent methods, which use protein...
Read more